|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss for the year | |||||
| Items not affecting cash: | |||||
| Amortization | |||||
| Fair value adjustment on derivative warrant liability | |||||
| Impairment of intangible assets | |||||
| Share-based payments | |||||
| Transaction costs on derivative warrant liability | |||||
| Unrealized foreign exchange (gain) loss | |||||
| Changes in non-cash operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses | |||||
| Accounts payable and accrued liabilities | |||||
| Cash flows from (used in) operating activities | |||||
| Investing activities | |||||
| Acquisition of intangible assets | |||||
| Acquisition of equipment | |||||
| Deferred acquisition costs | |||||
| Cash flows from (used in) investing activities | |||||
| Financing activities | |||||
| Pre-funded warrants and warrants exercised | |||||
| Payment of lease obligation | |||||
| Cash share issuance costs | |||||
| Proceeds from issuance of equity instruments | |||||
| Net cash flows from (used in) financing activities | |||||
| Effect of foreign exchange loss (gain) on cash | |||||
| Decrease in cash | |||||
| Cash, beginning of year | |||||
| Cash, end of year | |||||
| Supplemental Cash Flow and Non-Cash Investing and Financing Activities Disclosure | |||||
| Fair value of agent's warrants | |||||
| Derivative warrant liability reclassified to share capital on exercise of warrants | |||||
| Recognition of right-of-use asset | |||||
| Deferred financing costs reclassified to share capital and transaction costs on derivative warrant liability | |||||
| Share issuance costs in accounts payable | |||||
| Deferred acquisition costs in accounts payable | |||||
Loading...
